5/10
Health Sciences
PCI event recognizes faculty trailblazers
A Penn Center for Innovation event on Wednesday will celebrate this year’s 100-plus patent awardees and honor individuals with the most impressive startups, inventions, devices, and deals.
A link between anti-malaria drugs and cancer treatments, explained
The Abramson Cancer Center study is the first to identify what drugs known as chloroquines are targeting when used for cancer treatment.
Modeling the most common form of vision loss in older adults
Age-related macular degeneration is the leading cause of vision loss in people older than 50. Kathleen Boesze-Battaglia and colleagues have developed a model system that mimics many features of the human condition, giving scientists a platform to gain a deeper understanding of risk factors and possible treatments.
To resolve inflammation, location matters
A single protein can both restrain the initiation of inflammation and help to actively resolve it, according to new research led by George Hajishengallis of the School of Dental Medicine. He and his colleague found that the type of cell that secretes the protein determines which activity the protein promotes.
All hands on deck: Fentanyl in Philadelphia
In 2017, fentanyl surpassed heroin as the leading drug involved in overdose deaths, increasing from 57 percent of opioid-related deaths in 2016 to 84 percent in 2017.
Racial disparities in sudden cardiac death rates cannot be explained by known risk factors
Despite controlling for factors including income, smoking, and cholesterol levels, black patients remain at high risk.
How to survive baseball’s ‘most fearsome injury’
There is one injury that can thwart both an all-star pitcher with the Chicago Cubs and a teen practicing to make the varsity team: a torn labrum.
The ‘immunorevolution’ has begun
Penn Medicine experts gathered for a panel discussion about their innovative new approach to harness the body’s own immune system to fight cancer.
Staying alert to the rare but real risks of acute flaccid myelitis
Sarah Hopkins, a pediatric neurologist at the Perelman School of Medicine and Children’s Hospital of Philadelphia, has seen an increase in cases of the paralyzing condition this year. She explains what parents and pediatricians should watch for.
Sniffing for science
In the “Citizen Science” course at the School of Veterinary Medicine’s Working Dog Center, Meghan Ramos and Tessa Seales work with dog owners to enhance their pups’ scent detection skills, with an eye toward bolstering the Center’s research.
In the News
The quest for treatments to keep weight off after Ozempic
Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.
FULL STORY →
Inside Penn’s transfer center
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →
Broad Street runners from Penn are racing with gyroscopes to study the Achilles tendon
Casey Jo Humbyrd and Josh Baxter of the Perelman School of Medicine and colleagues will track data from running the Broad Street Run to understand how a healthy Achilles tendon functions.
FULL STORY →
What is topical steroid withdrawal? If you have eczema, here’s what you should know
Bruce Brod of the Perelman School of Medicine says that prolonged or overuse of topical steroids can cause rosacea, skin thinning, stretch marks, and an extreme and debilitating withdrawal.
FULL STORY →